Showing results (81-90 of 2,255) with videos related to

Sort By:
Pageof 226
Wiener Klinische Wochenschrift|January 1, 1993
[The medical historiographer Max Neuburger and the Vienna medical faculty]G Schmidt
Tropical Medicine and Parasitology : Official Organ of Deutsche Tropenmedizinische Gesellschaft and of Deutsche Gesellschaft Fur Technische Zusammenarbeit (GTZ)|June 1, 1989
Efficacy of bites from Asiatic and African tarantulasG Schmidt
Forensic Science International|March 1, 1979
Rib-cage injuries indicating the direction and strength of impactG Schmidt
Der Anaesthesist|July 2, 2003
[The use of neuromuscular monitoring in Germany]T Fuchs-Buder, R Hofmockel, G Geldner, et al.
Der Anaesthesist|May 17, 2003
[The use of muscle relaxants for routine induction of anesthesia in Germany]G Geldner, T Fuchs-Buder, R Hofmockel, et al.
Breast Cancer Research and Treatment|January 1, 1993
Urokinase (uPA) and its inhibitor PAI-1 are strong and independent prognostic factors in node-negative breast cancerF Jänicke, M Schmitt, L Pache, et al.
Thorax|March 27, 1999
Silica dust and lung cancer in the German stone, quarrying, and ceramics industries: results of a case-control studyK Ulm, B Waschulzik, H Ehnes, et al.
Cancer Research|March 1, 1985
Cytotoxicity of the alkyl-linked lipoidal amine 4-aminomethyl-1-[2,3-(di-n-decyloxy)-n-propyl]-4-phenylpiperidine (CP-46,665) in cells from human tumors and leukemiasW E Berdel, H D Schick, U Fink, et al.
Archives of Toxicology|January 1, 1995
Increased incidence of renal cell tumors in a cohort of cardboard workers exposed to trichloroetheneD Henschler, S Vamvakas, M Lammert, et al.
Cancer Research|May 15, 1994
Both the cytosols and detergent extracts of breast cancer tissues are suited to evaluate the prognostic impact of the urokinase-type plasminogen activator and its inhibitor, plasminogen activator inhibitor type 1F Jänicke, L Pache, M Schmitt, et al.
Pageof 226